| miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice MP Boldin, KD Taganov, DS Rao, L Yang, JL Zhao, M Kalwani, ... The Journal of experimental medicine 208 (6), 1189, 2011 | 1010 | 2011 |
| Antibody-based protection against HIV infection by vectored immunoprophylaxis AB Balazs, J Chen, CM Hong, DS Rao, L Yang, D Baltimore Nature 481 (7379), 81-84, 2012 | 636 | 2012 |
| miR-146a controls the resolution of T cell responses in mice L Yang, MP Boldin, Y Yu, CS Liu, CK Ea, P Ramakrishnan, KD Taganov, ... Journal of Experimental Medicine 209 (9), 1655-1670, 2012 | 332 | 2012 |
| Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma T Chodon, B Comin-Anduix, B Chmielowski, RC Koya, Z Wu, M Auerbach, ... Clinical Cancer Research 20 (9), 2457-2465, 2014 | 263 | 2014 |
| Engineered lentivector targeting of dendritic cells for in vivo immunization L Yang, H Yang, K Rideout, T Cho, K Joo, L Ziegler, A Elliot, A Walls, D Yu, ... Nature biotechnology 26 (3), 326-334, 2008 | 251 | 2008 |
| Targeting lentiviral vectors to specific cell types in vivo L Yang, L Bailey, D Baltimore, P Wang Proceedings of the National Academy of Sciences 103 (31), 11479-11484, 2006 | 212 | 2006 |
| Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes. XM Luo, E Maarschalk, RM O'Connell, P Wang, L Yang, D Baltimore Blood, The Journal of the American Society of Hematology 113 (7), 1422-1431, 2009 | 145 | 2009 |
| Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells L Yang, D Baltimore Proceedings of the National Academy of Sciences 102 (12), 4518-4523, 2005 | 137 | 2005 |
| miR-146a modulates autoreactive Th17 cell differentiation and regulates organ-specific autoimmunity B Li, X Wang, IY Choi, YC Wang, S Liu, AT Pham, H Moon, DJ Smith, ... The Journal of clinical investigation 127 (10), 3702-3716, 2017 | 129 | 2017 |
| Method for the generation of antigen-specific lymphocytes L Yang, L Van Parijs, D Baltimore US Patent 7,939,059, 2011 | 126 | 2011 |
| Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat D Coss, L Yang, CB Kuo, X Xu, RA Luben, AM Walker American Journal of Physiology-Endocrinology And Metabolism 279 (6), E1216-E1225, 2000 | 124 | 2000 |
| Off-the-shelf CAR-NK cells for cancer immunotherapy EL Siegler, Y Zhu, P Wang, L Yang Cell stem cell 23 (2), 160-161, 2018 | 121 | 2018 |
| Central infusions of the recombinant human prolactin receptor antagonist, S179D-PRL, delay the onset of maternal behavior in steroid-primed, nulliparous female rats RS Bridges, BA Rigero, EM Byrnes, L Yang, AM Walker Endocrinology 142 (2), 730-739, 2001 | 107 | 2001 |
| Inhibitory effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice EM Hur, SN Patel, S Shimizu, DS Rao, PNP Gnanapragasam, DS An, ... Blood, The Journal of the American Society of Hematology 120 (23), 4571-4582, 2012 | 96 | 2012 |
| Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy YC Wang, X Wang, J Yu, F Ma, Z Li, Y Zhou, S Zeng, X Ma, YR Li, A Neal, ... Nature communications 12 (1), 3530, 2021 | 82 | 2021 |
| Creatine uptake regulates CD8 T cell antitumor immunity S Di Biase, X Ma, X Wang, J Yu, YC Wang, DJ Smith, Y Zhou, Z Li, YJ Kim, ... Journal of Experimental Medicine 216 (12), 2869-2882, 2019 | 82 | 2019 |
| Lentiviral vector delivery of human interleukin-7 (hIL-7) to human immune system (HIS) mice expands T lymphocyte populations RM O'Connell, AB Balazs, DS Rao, C Kivork, L Yang, D Baltimore PLoS One 5 (8), e12009, 2010 | 77 | 2010 |
| HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells B Dai, L Yang, H Yang, B Hu, D Baltimore, P Wang Proceedings of the National Academy of Sciences 106 (48), 20382-20387, 2009 | 73 | 2009 |
| Isolation and characterization of NY-ESO-1–specific T cell receptors restricted on various MHC molecules MT Bethune, XH Li, J Yu, J McLaughlin, D Cheng, C Mathis, BH Moreno, ... Proceedings of the National Academy of Sciences 115 (45), E10702-E10711, 2018 | 66 | 2018 |
| Development of hematopoietic stem cell-engineered invariant natural killer T cell therapy for cancer Y Zhu, DJ Smith, Y Zhou, YR Li, J Yu, D Lee, YC Wang, S Di Biase, ... Cell Stem Cell 25 (4), 542-557. e9, 2019 | 61 | 2019 |
